New stem cell transplant trial by Queen Mary’s may help cure pain of Crohn’s disease
- Credit: QMUL
A clinical trial has begun by researchers at Whitechapel using stem cell transplants to grow new immune systems for people with untreatable Crohn’s disease.
The £2m study led by Queen Mary University is recruiting patients around the country in search of a cure for the painful and chronic intestinal disease.
Helen Bartlett has already had a transplant after being in and out of hospital for 20 years.
“Living with Crohn’s is a daily struggle,” she said. “I’ve had operation after operation, drug after drug. It’s depressing and you just feel so low.
“I cannot describe how much better I feel since my transplant. I’m not in that constant pain.”
You may also want to watch:
Crohn’s disease causes inflammation of the digestive system and results in diarrhoea, pain and extreme tiredness. Treatments include drugs to reduce inflammation, but surgery is often needed to remove the affected part of the bowel.
Queen Mary’s Prof James Lindsay, a Barts Health Trust consultant, said: “We’re hoping we might be able to alter the course of the disease by resetting the patient’s immune system through a stem cell transplant. It may not be a cure, but may allow some patients to respond to drugs which previously didn’t work.”
- 1 Man sentenced after teenage boy groomed on Snapchat to sell heroin
- 3 NHS nurse assaulted at east London hospital
- 4 Covid vaccination hub opening in Westfield next week
- 5 Council fined for Alexia Walenkaki's playground death in Mile End and says sorry to family
- 6 Airbnb house party violence leaves police officer with broken finger
- 7 Police hunt after stabbing in Cable Street: One man hurt
- 8 Death of woman, 75, in Mile End fire could have been avoided
- 9 Ethnic communities not taking up Covid jabs, Tower Hamlets Mayor warns
- 10 Man sentenced for assault on Homerton Hospital nurse
Stem cell transplants have been successful treating multiple sclerosis. This trial will see whether similar treatment could offer hope to those with Crohn’s disease.